Page last updated: 2024-08-23

1-deoxynojirimycin and Angiogenesis, Pathologic

1-deoxynojirimycin has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, PV; O'Boyle, KM; Zhao, Y; Zhou, Y1
Chang, J; Chrest, FJ; Mueller, RA; Partis, RA; Passaniti, A; Pili, R1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Angiogenesis, Pathologic

ArticleYear
Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
    Bioorganic & medicinal chemistry, 2008, Jun-15, Volume: 16, Issue:12

    Topics: 1-Deoxynojirimycin; Aminopeptidases; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Cattle; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cyclin D1; Endothelial Cells; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Metalloendopeptidases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Stress Fibers; Triazoles

2008
The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
    Cancer research, 1995, Jul-01, Volume: 55, Issue:13

    Topics: 1-Deoxynojirimycin; Animals; Cell Adhesion; Cell Aggregation; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Endothelium; Glucosamine; Glycoconjugates; Glycoside Hydrolase Inhibitors; Glycosylation; Growth Inhibitors; In Vitro Techniques; Indolizines; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Processing, Post-Translational

1995